Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. (Lantus-P-CN) - Trial 2014-004640-35
Access comprehensive clinical trial information for 2014-004640-35 through Pure Global AI's free database. This phase not specified trial is sponsored by Sanofi and is currently status unknown. The study focuses on Type 1 Diabetes Mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-004640-35
Trial Details
EU Clinical Trials Register • 2014-004640-35
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. (Lantus-P-CN)
Study Focus
Sponsor & Location
Sanofi
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Treatment with oral or parenteral glucose-lowering medications other than insulin. HbA1c < 7% or > 12 % at screening.
ICD-10 Classifications
Type 1 diabetes mellitus
Type 1 diabetes mellitus with unspecified complications
Type 1 diabetes mellitus with other specified complications
Type 1 diabetes mellitus without complications
Type 1 diabetes mellitus with multiple complications
Data Source
EU Clinical Trials Register
2014-004640-35
Non-Device Trial